1. Ventajas del uso de citrato respecto al acetato como estabilizante en el líquido de hemodiálisis: estudio aleatorizado ABC-treat
- Author
-
Maria Jesús Camba, Evangelina Mérida, Manuel Molina, en representación del grupo del estudio ABC-treat, Rafael Pérez-García, Maria Paz Alcaide, Luis Alberto Blázquez, Patricia de Sequera, Rocio Echarri, Rosa Inés Muñoz-González, and Gracia Álvarez-Fernández
- Subjects
medicine.medical_specialty ,business.industry ,Magnesium ,medicine.medical_treatment ,Bicarbonate ,chemistry.chemical_element ,Calcium ,Gastroenterology ,law.invention ,chemistry.chemical_compound ,Acetic acid ,chemistry ,Randomized controlled trial ,Nephrology ,law ,Internal medicine ,medicine ,Lean body mass ,Hemodialysis ,business ,Dialysis - Abstract
Hemodialysis (HD) with bicarbonate dialysis fluid (DF) requires the presence of an acid to prevent the precipitation of calcium and magnesium carbonate. The most used acid is acetic acid, with it several complications have been described. In a previous work, we described the acute changes during an HD session with a DF with citrate instead of acetate. Now, we report the results in the medium term, 16 weeks. It is a prospective, multicenter, crossover and randomized study, where 56 HD patients with bicarbonate three times a week were dialysed for 16 weeks with 3mmol/L acetate and 16 weeks with 1mmol/L citrate. Patients older than 18 years with a previous stay on HD of more than 3 months and with a normal functioning arteriovenous fistula were included. Epidemiological data, dialysis, bioimpedance, biochemistry before and after HD, as well as hypotensive episodes, were collected monthly. After 16 weeks of citrate treatment, pre-HD ionic calcium and magnesium were significantly lower and paratiroid hormone (PTH) higher than in the acetate period. No differences were observed in the effectiveness of dialysis. Hypotensive episodes were significantly more frequent with acetate than with citrate: 311 (14.1%) vs 238 (10.8%) sessions. The lean mass index increased by 0.96±2.33kg/m2 when patients switched from DF with acetate to citrate. HD with citrate modifies several parameters of bone mineral metabolism, not only acutely as previously described, but also in the long-term. The substitution of acetate for citrate improves hemodynamic stability, producing less hypotension and can improve nutritional status.
- Published
- 2022